Cargando…

Kudo K, Kubota Y, Toki T, et al. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report. Blood Adv. 2022;6(10):3162-3166.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806331/ https://www.ncbi.nlm.nih.gov/pubmed/36538344 http://dx.doi.org/10.1182/bloodadvances.2022008428

Ejemplares similares

Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report
por: Kudo, Ko, et al.
Publicado: (2022)

Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
Publicado: (2022)

Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.
Publicado: (2023)

Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Adv. 2022;6(21):5774-5785.
Publicado: (2023)

van Rhee F, Rosenthal A, Kanhai K, et al. Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Adv. 2022;6(16):4773-4781.
Publicado: (2023)

Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731.
Publicado: (2023)

Karihtala K, Leivonen S-K, Karjalainen-Lindsberg M-L, et al. Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients. Blood Adv. 2022;6(6):1919-1931.
Publicado: (2023)

Lisi V, Blanchard È, Vladovsky M, et al. Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia. Blood Adv. 2022;6(17):5160-5164.
Publicado: (2023)

Nawas MT, Sanchez-Escamilla M, Devlin SM, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898-5907.
Publicado: (2023)

Smith CC, Levis MJ, Perl AE, et al. Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib. Blood Adv. 2022;6(7):2144-2155.
Publicado: (2022)

Erratum to “Cardiac Damage Staging Classification in Asymptomatic Moderate or Severe Primary Mitral Regurgitation”: [Structural Heart 2022;6(1):100004]
Publicado: (2023)

Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
Publicado: (2023)

Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.
Publicado: (2023)

Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv. 2022;6(3):828-847.
Publicado: (2023)

Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
Publicado: (2022)

Kudos Section
por: Usichenko, Taras
Publicado: (2006)

Kudos to The Virus Hunters
por: Mathew, BC, et al.
Publicado: (2009)

Common variation at 10p12.31 near MLLT10 influences meningioma risk
por: Dobbins, Sara E, et al.
Publicado: (2011)

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL
por: Kang, Huining, et al.
Publicado: (2018)

Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers
por: Walsh, Kyle M, et al.
Publicado: (2022)

LHC MDs 3163, 3164, and 3166: Injection oscillations throughout the cycle
por: Timko, Helga, et al.
Publicado: (2019)

Erratum to: The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
Publicado: (2023)

Correction: Kudo, K. Localization Detection Based on Quantum Dynamics. Entropy 2022, 24, 1085
por: Kudo, Kazue
Publicado: (2022)

Designing Magnetism in High Entropy Oxides (Adv. Sci. 10/2022)
por: Mazza, Alessandro R., et al.
Publicado: (2022)

The Association of the Copy Number Variation of the MLLT10 Gene with Growth Traits of Chinese Cattle
por: Yang, Peng, et al.
Publicado: (2020)

FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses
por: Mekhail, Katrina, et al.
Publicado: (2022)

Shin-ei Kudo, MD, PhD
Publicado: (2020)

4th International Toki Conference on Plasma Physics and Controlled Nuclear Fusion
por: Guyenne, T D, et al.
Publicado: (1993)

The Leukemia-Associated Mllt10/Af10-Dot1l Are Tcf4/β-Catenin Coactivators Essential for Intestinal Homeostasis
por: Mahmoudi, Tokameh, et al.
Publicado: (2010)

Lissitchkov T, Willemze A, Katragadda S, et al. Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022;6(4):1089-1094.
Publicado: (2022)

Correction: The Leukemia-Associated Mllt10/Af10-Dot1l Are Tcf4/β-Catenin Coactivators Essential for Intestinal Homeostasis
por: Mahmoudi, Tokameh, et al.
Publicado: (2017)

Mllt10 knockout mouse model reveals critical role of Af10-dependent H3K79 methylation in midfacial development
por: Ogoh, Honami, et al.
Publicado: (2017)

Kudos to Reviewers for the JGP: You Make Our Science Better
por: Pugh, Edward N.
Publicado: (2009)

Eshel A, Sharon I, Nagler A, et al. Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. Blood Adv. 2022;6(2):568-573.
Publicado: (2022)

Shouval R, Fein JA, Cho C, et al. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT. Blood Adv. 2022;6(5):1525-1535.
Publicado: (2022)

Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
Publicado: (2022)

3162 Colonization of Pregnant Women with Group B streptococcus in Latin America and Infant Outcomes
por: HogenEsch, Elena, et al.
Publicado: (2019)

Contents: (Adv. Sci. 10/2016)
Publicado: (2016)

Masthead: (Adv. Sci. 10/2016)
Publicado: (2016)

Masthead: (Adv. Sci. 10/2015)
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ardfrbd8aeeqnk4v0usfr7r921